<!doctype html><html><head><meta charset=utf-8><title>Vaginosis not reduced by average of 2800 IU vitamin D daily – RCT</title>
<link rel=stylesheet href="/css/main.css?v=1753298154"><link rel=stylesheet href="/css/pagination.css?v=1753298154"><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css><script src="/js/search-suggestions.js?v=1753298154"></script><script src="/js/search.js?v=1753298154"></script><script type=module>
        
        window.initPagefind = async function() {
            try {
                console.log('Loading Pagefind module...');
                window.pagefind = await import('/pagefind/pagefind.js');
                if (!window.pagefind) {
                    throw new Error('Failed to load Pagefind module - import returned empty result');
                }
                
                console.log('Initializing Pagefind...');
                const initResult = await window.pagefind.init();
                console.log('Pagefind loaded and initialized');
                
                
                if (window.searchInstance) {
                    console.log('Notifying Search instance of Pagefind initialization');
                    window.searchInstance.initializePagefind(window.pagefind);
                    console.log('Search instance successfully notified');
                } else {
                    console.warn('Search instance not found in global scope yet, but Pagefind is loaded');
                    
                }
            } catch (error) {
                console.error('CRITICAL ERROR: Failed to initialize Pagefind:', error);
                
                const errorDetails = error.stack || error.message || String(error);
                console.error('Error details:', errorDetails);
                
                
                const statusEl = document.querySelector('#search-status');
                const inputEl = document.querySelector('#search-input');
                
                if (statusEl) {
                    statusEl.textContent = 'Search unavailable: ' + error.message;
                    statusEl.style.display = 'block';
                    statusEl.style.color = 'red';
                }
                
                if (inputEl) {
                    inputEl.disabled = true;
                    inputEl.placeholder = 'Search unavailable';
                }
            }
        };
        
        
        window.pagefindInitialized = false;
        
        
        document.addEventListener('DOMContentLoaded', () => {
            console.log('DOM loaded, initializing Pagefind...');
            window.initPagefind();
        });
    </script></head><body><div class=top-nav><div class=home-icon><a href=/ title="Go to Home Page"><svg viewBox="0 0 576 512" width="28" height="28"><path d="M575.8 255.5c0 18-15 32.1-32 32.1h-32l.7 160.2c0 2.7-.2 5.4-.5 8.1V472c0 22.1-17.9 40-40 40H456c-1.1.0-2.2.0-3.3-.1-1.4.1-2.8.1-4.2.1H416 392c-22.1.0-40-17.9-40-40V448 384c0-17.7-14.3-32-32-32H256c-17.7.0-32 14.3-32 32v64 24c0 22.1-17.9 40-40 40H160 128.1c-1.5.0-3-.1-4.5-.2-1.2.1-2.4.2-3.6.2H104c-22.1.0-40-17.9-40-40V360c0-.9.0-1.9.1-2.8V287.6H32c-18 0-32-14-32-32.1.0-9 3-17 10-24L266.4 8c7-7 15-8 22-8s15 2 21 7L564.8 231.5c8 7 12 15 11 24z"/></svg></a></div><div class=search-container><div class=search-icon><i class="fas fa-search"></i></div><input type=text id=search-input placeholder=Search... disabled><div id=suggestions class=search-suggestions style=display:none></div><ul id=search-results style=display:none></ul><div id=search-results-panel class=search-results-panel><div class=results-header>Search Results</div><ul id=search-results-panel-list class=results-list></ul></div></div></div><div class=container><div class="content content-full-width" role=main><article><div class=scroll-nav-top><a href=javascript:void(0); id=scroll-to-bottom class=scroll-button aria-label="Scroll to bottom" onclick='return window.scrollTo({top:document.body.scrollHeight,behavior:"smooth"}),!1'><svg width="16" height="16" fill="currentcolor" viewBox="0 0 16 16"><path d="M8 4a.5.5.0 01.5.5v5.793l2.146-2.147a.5.5.0 01.708.708l-3 3a.5.5.0 01-.708.0l-3-3a.5.5.0 11.708-.708L7.5 10.293V4.5A.5.5.0 018 4z"/></svg>
<span>Scroll to Bottom</span></a></div><h1>Vaginosis not reduced by average of 2800 IU vitamin D daily – RCT</h1><time>October 29, 2014</time><div data-pagefind-body><h3 id=a-blinded-randomized-controlled-trial-of-high-dose-vitamin-d-supplementation-to-reduce-recurrence-of-bacterial-vaginosis>A blinded, randomized controlled trial of high-dose vitamin D supplementation to reduce recurrence of bacterial vaginosis</h3><p>American Journal of Obstetrics & Gynecology, Volume 211, Issue 5, Pages 479.e1–479.e13, November 2014</p><p>Presented at the joint meeting of the International Society for Sexually Transmitted Disease Research and the International Union against Sexually Transmitted Infections, Vienna, Austria, July 13-17, 2013.</p><p>Abigail Norris Turner, PhDemail, Patricia Carr Reese, MPH, Karen S. Fields, RN, Julie Anderson, MPH, Melissa Ervin, MT(ASCP), John A. Davis, MD, PhD, Raina N. Fichorova, MD, PhD, Mysheika Williams Roberts, MD, MPH, Mark A. Klebanoff, MD, MPH, Rebecca D. Jackson, MD</p><p>Received: April 2, 2014; Received in revised form: May 24, 2014; Accepted: June 11, 2014; Published Online: June 17, 2014</p><p>DOI: <a href=http://dx.doi.org/10.1016/j.ajog.2014.06.023>http://dx.doi.org/10.1016/j.ajog.2014.06.023</a></p><div class=border style="background-color:#ff9;padding:15px;margin:10px 0;border-radius:5px;width:600"><p>Several previous studies found that higher level of vitamin D is needed</p><p>For example: 6,000 IU per day has been successful with white women</p><p>This study used an average of 2800 IU ( 50,000 IU/ 18 days)</p><p>And, 74% of the participants were Black – so probably would need > 6,000 IU</p><p>Suspect that researchers would find benefit for women achieving > 40ng/ml level of vitamin D</p><p><strong><i class="fas fa-file-pdf" style=margin-right:.3em></i><a href=https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/bacterial-vaginosis.pdf>Download the PDF from VitaminDWiki.</a></strong></p><h4 id=see-also-vitamindwiki>See also VitaminDWiki</h4><ul><li><p><a href=/posts/overview-women-and-vitamin-d style=color:red;text-decoration:underline title="This post/category does not exist yet: Overview Women and Vitamin D">Overview Women and Vitamin D</a></p></li><li><p><a href=/posts/vaginal-vitamin-d-reduced-vaginal-infections>Vaginal Vitamin D reduced vaginal infections - Jan 2014</a></p></li><li><p><a href=/posts/vaginal-suppository-of-6300-iu-vitamin-d-stopped-vaginal-infection style=color:red;text-decoration:underline title="This post/category does not exist yet: Vaginal suppository of 6300 IU vitamin D stopped vaginal infection – Feb 2011">Vaginal suppository of 6300 IU vitamin D stopped vaginal infection – Feb 2011</a> previous report by Jan 2014 authors</p></li><li><p><a href=/posts/all-of-the-top-10-health-problems-of-women-are-associated-with-low-vitamin-d>ALL of the top 10 health problems of women are associated with low vitamin D</a></p></li></ul></div><p>Objective</p><p>Low serum vitamin D levels have been associated with increased prevalence of the reproductive tract condition bacterial vaginosis (BV). The objective of this trial was to evaluate the effect of high-dose vitamin D supplementation on BV recurrence.</p><p>Study Design</p><p>This randomized, placebo-controlled, double-blinded trial enrolled 118 women with symptomatic BV from an urban sexually transmitted disease clinic (clinicaltrials.gov registration NCT01450462). All participants received 500 mg of oral metronidazole twice daily for 7 days. Intervention participants (n = 59) also received 9 doses of 50,000 IU of cholecalciferol (vitamin D3) over 24 weeks; control women (n = 59) received matching placebo. Recurrent BV was assessed via Nugent scoring after 4, 12, and 24 weeks. We assessed the effect of the intervention using an intention-to-treat approach, fitting Cox proportional hazards models to evaluate recurrent BV over the follow-up period.</p><p>Results</p><p><strong>Most participants (74%) were black</strong> , with a median age of 26 years. Median presupplementation serum 25-hydroxyvitamin D <span>[25(OH)D]</span> was similar across randomization arms: 16.6 ng/mL in the vitamin D arm and 15.8 ng/mL in the control arm. At trial completion, median 25(OH)D among women receiving vitamin D was <strong>30.5 ng/mL, vs 17.8 ng</strong> /mL in control women; 16% of women receiving vitamin D and 57% receiving placebo remained vitamin D deficient (&lt;20 ng/mL). BV prevalence among women randomized to vitamin D was very similar to those randomized to placebo at the 4- and 12-week visits, but by the 24-week visit, BV prevalence was 65% among women in the vitamin D arm and 48% among control women. BV recurrence was not reduced by vitamin D supplementation (intention-to-treat hazard ratio, 1.11; 95% confidence interval, 0.68–1.81). Among women experiencing recurrent BV, median time to recurrence was 13.7 weeks in the vitamin D arm and 14.3 weeks in the control arm.</p><p>Conclusion</p><p>Women receiving vitamin D experienced significant increases in serum 25(OH)D, but this increase was not associated with decreased BV recurrence in this high-risk sexually transmitted disease clinic population.</p></div><hr class=tag-separator><div class=tags><span>Tags: </span><a href=/tags/blood-levels.html><span class=tag>blood levels</span></a>
<a href=/tags/dosage.html><span class=tag>dosage</span></a>
<a href=/tags/vitamin-d.html><span class=tag>vitamin d</span></a>
<a href=/tags/vitamin-d-blood-test.html><span class=tag>vitamin d blood test</span></a>
<a href=/tags/women.html><span class=tag>Women</span></a></div><div data-pagefind-meta=tags hidden>blood levels, dosage, vitamin d, vitamin d blood test, Women</div><div class=scroll-nav-bottom id=article-bottom><a href=javascript:void(0); id=scroll-to-top class=scroll-button aria-label="Scroll to top" onclick='return window.scrollTo({top:0,behavior:"smooth"}),!1'><svg width="16" height="16" fill="currentcolor" viewBox="0 0 16 16"><path d="M8 12a.5.5.0 00.5-.5V5.707l2.146 2.147a.5.5.0 00.708-.708l-3-3a.5.5.0 00-.708.0l-3 3a.5.5.0 10.708.708L7.5 5.707V11.5a.5.5.0 00.5.5z"/></svg>
<span>Back to Top</span></a></div></article></div></div><script src="/js/toc-sanitizer.js?v=1753298154"></script><script src="/js/tiki-redirects.js?v=1753298154"></script><script src="/js/lightspa.js?v=1753298154"></script><script>const spa=new LightSPA({mainContentSelector:'[role="main"]',navigationSelector:"[data-spa-nav]"});window.search=new Search({documentsUrl:"/search/search_documents.json.gz?v=1753298154",indexUrl:"/search/search_index.json.gz?v=1753298154"}),document.addEventListener("DOMContentLoaded",function(){function e(e){var t=e.querySelector(".category-expander"),n=e.querySelector(".subcategory-list");e.classList.contains("collapsed")?(e.classList.remove("collapsed"),e.classList.add("expanded"),t.textContent="-",n.style.display="block"):(e.classList.remove("expanded"),e.classList.add("collapsed"),t.textContent="+",n.style.display="none")}document.querySelectorAll(".category-expander").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})}),document.querySelectorAll(".category-name").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})})})</script><script src="/js/scroll-buttons.js?v=1753298154"></script></body></html>